Skip to main content
. Author manuscript; available in PMC: 2020 Apr 2.
Published in final edited form as: Gastroenterology. 2020 Jan 13;158(5):1465–1496.e17. doi: 10.1053/j.gastro.2020.01.007

Table 12.

GRADE Evidence Profile comparing antibiotics vs. placebo in hospitalized patients with acute severe ulcerative colitis, without gastrointestinal infection.


Adjuvant Antibiotic Therapy Compared to Placebo for Hospitalized Patients with acute severe ulcerative colitis, without gastrointestinal infection
Outcomes Study event rates (95% CI) Relative effect (95% CI) Absolute effect* No of participants (studies) Quality of the evidence (GRADE)
Risk with Placebo Risk with Antibiotics
Short-term colectomy 26/81 (32.1%) 20/85 (23.5%) RR 0.79 (0.46 to 1.35) 67 fewer per 1,000 (from 173 fewer to 112 more) 166 (4 RCTs) ⨁◯◯◯1,2,3 VERY LOW
GRADE Working Group grades of evidence
High quality: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate quality: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different
Low quality: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low quality: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect
1

Rated down for risk of bias (random sequence generation, allocation concealment, unclear risk of bias in blinding of outcome assessors/analysts)

2

Rated down for very serious imprecision

3

Rated down for inconsistency (in intervention – different antibiotics used)